Aortic Aneurysm Market Size, Share, Growth, and Industry Analysis, By Type (Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm (TAA)), By Application (Hospitals and Clinics, Ambulatory Surgery Centers (ASCs), Others), Regional Insights and Forecast to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

AORTIC ANEURYSM MARKET OVERVIEW

The global Aortic Aneurysm Market size estimated at USD 4.66 billion in 2026 and is projected to reach USD 7.87 billion by 2035, growing at a CAGR of 5.99% from 2026 to 2035.

The Aortic Aneurysm Market is expanding due to the increasing prevalence of cardiovascular disorders, aging populations, and wider adoption of minimally invasive endovascular procedures. More than 200,000 people are diagnosed with aortic aneurysms annually across major healthcare markets, while abdominal aortic aneurysm affects nearly 5% of men aged above 65 years. Endovascular aneurysm repair now accounts for approximately 72% of elective abdominal aneurysm procedures in developed healthcare systems because of reduced hospital stays and lower perioperative complications. More than 1.3 million vascular imaging examinations are performed annually for aneurysm screening, surveillance, and diagnosis, supporting continuous demand for stent grafts, imaging systems, and advanced surgical devices within the Aortic Aneurysm Market.

The United States remains the largest national market for aortic aneurysm diagnosis and treatment owing to advanced healthcare infrastructure and nationwide screening initiatives. More than 1.1 million Americans are estimated to live with an aortic aneurysm, while approximately 200,000 new diagnoses are reported every year. Around 30,000 abdominal aortic aneurysm repair procedures are performed annually, with endovascular repair representing nearly 80% of elective interventions. Men account for approximately 75% of diagnosed abdominal aneurysm cases, while smoking contributes to over 70% of preventable aneurysm risk. More than 6,000 hospitals across the country provide vascular surgical services supporting continued market expansion.

KEY FINDINGS

LATEST TRENDS

The Aortic Aneurysm Market is witnessing significant transformation through technological innovation, earlier diagnosis, and increasing utilization of minimally invasive vascular interventions. Endovascular aneurysm repair now represents approximately 72% of elective abdominal aneurysm procedures because patients experience shorter hospitalization periods averaging 2 days compared with approximately 7 days following conventional open surgery. More than 85% of vascular centers utilize high-resolution computed tomography angiography for treatment planning, improving procedural precision and graft selection.

Artificial intelligence-assisted image interpretation has expanded to nearly 29% of advanced hospitals, reducing diagnostic variability and improving anatomical assessment. Fenestrated and branched stent graft adoption has increased by approximately 24%, enabling treatment of anatomically complex aneurysms previously managed through open procedures. Physician preference for low-profile delivery systems has exceeded 68%, allowing treatment through smaller vascular access points. Clinical follow-up compliance has improved to approximately 78% because of digital patient monitoring platforms and standardized surveillance protocols.

MARKET DYNAMICS

Driver

Rising demand for minimally invasive vascular interventions.

The strongest growth driver for the Aortic Aneurysm Market is the increasing preference for minimally invasive endovascular aneurysm repair. Approximately 72% of elective abdominal aneurysm repairs are currently performed using endovascular techniques because patients benefit from reduced blood loss, lower perioperative complications, and shorter recovery periods. More than 80% of vascular surgeons in developed healthcare systems routinely recommend endovascular repair for anatomically suitable patients. The population aged above 65 years continues to expand globally, increasing the number of individuals requiring aneurysm screening and treatment.

Restraint

High treatment complexity and limited patient eligibility.

Despite technological advancements, several clinical limitations continue to restrain market expansion. Approximately 28% of diagnosed aneurysm patients are not suitable candidates for standard endovascular repair because of unfavorable vascular anatomy or severe calcification. Nearly 31% of aneurysms remain undetected until advanced disease stages because early symptoms are often absent. Complex thoracic aneurysms frequently require customized branched or fenestrated grafts that are available only in specialized vascular centers. Follow-up imaging remains essential after endovascular repair, with surveillance extending beyond 5 years in many patients.

Expansion of screening programs and personalized vascular devices

Opportunity

Significant opportunities exist through broader implementation of national aneurysm screening initiatives and development of patient-specific vascular implants. Population-based screening has demonstrated detection improvements exceeding 40% among high-risk individuals older than 65 years.

More than 1.3 million vascular imaging examinations are performed annually across leading healthcare markets, creating sustained demand for diagnostic technologies and endovascular devices. Customized fenestrated stent graft utilization has increased by approximately 24%, enabling treatment of complex aneurysm anatomies previously requiring open surgery.

Maintaining long-term clinical outcomes and surveillance compliance

Challenge

Long-term post-procedural surveillance remains one of the largest challenges within the Aortic Aneurysm Market. Approximately 18% of endovascular patients require secondary interventions because of endoleaks, graft migration, or structural complications identified during follow-up imaging.

Clinical surveillance protocols recommend periodic computed tomography or ultrasound examinations extending beyond 5 years, increasing healthcare utilization. Nearly 37% of patients demonstrate inconsistent compliance with long-term imaging recommendations, creating challenges for physicians monitoring graft durability.

•   
•   
  

  Download Free Sample to learn more about this report

    

AORTIC ANEURYSM MARKET SEGMENTATION

By Type

• Abdominal Aortic Aneurysm (AAA): Abdominal Aortic Aneurysm (AAA) represents the largest segment of the Aortic Aneurysm Market with approximately 69% market share owing to its higher prevalence among elderly individuals and smokers. Nearly 5% of men aged above 65 years develop abdominal aneurysms, while women account for approximately 20% of diagnosed AAA cases. More than 30,000 AAA repair procedures are performed annually in the United States, with nearly 80% completed using endovascular aneurysm repair. Screening initiatives targeting high-risk populations have improved early diagnosis rates by approximately 25% over recent years.

• Thoracic Aortic Aneurysm (TAA): Thoracic Aortic Aneurysm (TAA) accounts for approximately 31% of the Aortic Aneurysm Market and continues to expand because of increasing use of computed tomography and magnetic resonance imaging. Thoracic aneurysms occur less frequently than abdominal aneurysms but require highly specialized treatment owing to anatomical complexity. Approximately 10 cases per 100,000 individuals are diagnosed annually in developed healthcare systems. Thoracic endovascular aortic repair has become the preferred treatment option for many eligible patients, representing nearly 65% of elective thoracic interventions.

By Application

• Hospitals and Clinics: Hospitals and Clinics dominate the Aortic Aneurysm Market with approximately 81% market share because they possess advanced vascular imaging systems, hybrid operating rooms, intensive care facilities, and multidisciplinary cardiovascular teams. More than 90% of emergency aneurysm repairs are performed in hospitals because ruptured aneurysms require immediate surgical intervention. Approximately 80% of elective endovascular aneurysm repair procedures also occur within specialized tertiary hospitals equipped with computed tomography angiography and advanced fluoroscopic imaging.

• Ambulatory Surgery Centers (ASCs): Ambulatory Surgery Centers (ASCs) account for approximately 13% of the Aortic Aneurysm Market and are gradually increasing their role in selected minimally invasive vascular procedures. Improvements in low-profile endovascular devices have enabled shorter procedure times and faster patient recovery, making outpatient treatment feasible for carefully selected individuals. Average patient discharge following uncomplicated procedures can occur within 24 hours in specialized centers. Approximately 35% of vascular outpatient facilities now perform diagnostic angiography and selected endovascular interventions.

• Others: The Others segment contributes approximately 6% of the Aortic Aneurysm Market and includes specialty cardiovascular institutes, military healthcare facilities, academic medical centers, and dedicated vascular research hospitals. These institutions frequently participate in clinical evaluations of next-generation stent grafts, advanced imaging software, and innovative vascular implants. More than 200 specialized cardiovascular research centers worldwide are involved in aneurysm-related clinical investigations. Academic institutions also perform physician training programs, anatomical simulation, and device performance assessments supporting continuous technological advancement.

•   
•   
  Download Free Sample to learn more about this report

    

AORTIC ANEURYSM MARKET REGIONAL INSIGHTS

• North America

North America holds the largest share of the global aortic aneurysm market, accounting for 38% of the overall market. The region benefits from advanced cardiovascular healthcare infrastructure, widespread availability of diagnostic imaging systems, and high adoption of endovascular aneurysm repair procedures. The United States represents the major contributor due to the presence of specialized vascular centers and increasing screening initiatives for abdominal aortic aneurysm among high-risk populations. More than 200,000 abdominal aortic aneurysm cases are diagnosed annually in the United States, supporting demand for advanced treatment solutions. Rising adoption of stent graft technologies and improved patient monitoring systems continue to strengthen the aortic aneurysm market in North America.

• Europe

Europe represents 27% of the global aortic aneurysm market, supported by established healthcare systems, increasing geriatric populations, and strong availability of vascular surgery expertise. Countries across Western Europe show higher adoption of advanced aneurysm repair techniques due to improved clinical guidelines and access to minimally invasive procedures. Abdominal aortic aneurysm screening programs have been implemented in several European countries to improve early detection among high-risk groups. The region experiences a significant burden of cardiovascular diseases, with aging populations contributing to increased demand for aortic aneurysm diagnosis, surveillance, and treatment solutions. Research activities and technological advancements in vascular devices continue to support market expansion.

• Asia-Pacific

Asia-Pacific accounts for 22% of the global aortic aneurysm market and is witnessing rapid development due to increasing cardiovascular disease awareness, expanding healthcare facilities, and growing access to advanced medical technologies. Countries such as China, Japan, and India are experiencing rising demand for aortic aneurysm treatment due to aging demographics and increasing prevalence of hypertension-related vascular conditions. The region has a large patient population, with cardiovascular diseases representing a major healthcare concern. Improvements in diagnostic imaging, increased adoption of endovascular repair methods, and government initiatives to enhance specialized healthcare services are driving the growth of the aortic aneurysm market across Asia-Pacific.

• Middle East & Africa

Middle East & Africa holds 8% of the global aortic aneurysm market, supported by improving healthcare infrastructure, rising investments in specialty hospitals, and growing awareness regarding cardiovascular disorders. The region is witnessing increased adoption of advanced diagnostic tools, including computed tomography angiography and ultrasound-based screening methods. Countries with developed healthcare systems are increasing their focus on vascular disease management and minimally invasive surgical procedures. The growing elderly population and increasing prevalence of risk factors such as hypertension and smoking are contributing to higher demand for aortic aneurysm treatment solutions. Healthcare modernization programs continue to create opportunities for market development.

• Rest of the World

Rest of the World contributes 5% of the global aortic aneurysm market, driven by gradual improvements in healthcare access, increasing diagnosis rates, and rising demand for specialized cardiovascular treatments. Latin America and other emerging regions are adopting advanced vascular technologies as healthcare providers improve treatment capabilities. The increasing burden of cardiovascular disorders and improved awareness regarding early detection are supporting the adoption of aneurysm management solutions. Investments in medical infrastructure and expansion of specialized healthcare services are helping improve access to diagnosis and treatment options. Growing acceptance of minimally invasive procedures is also supporting the development of the aortic aneurysm market in these regions.

KEY INDUSTRY PLAYERS

The aortic aneurysm market includes major global medical device manufacturers, cardiovascular technology companies, and emerging vascular solution providers competing through product innovation, strategic partnerships, and advanced treatment technologies. Leading companies focus on developing endovascular stent grafts, imaging technologies, and minimally invasive repair systems to improve patient outcomes. Competitive strategies include clinical research investments, expansion of vascular product portfolios, and collaborations with healthcare institutions. Established players maintain strong market positioning through extensive distribution networks and regulatory approvals, while emerging companies are introducing innovative solutions focused on improved procedural efficiency and patient safety. The competitive landscape continues evolving with advancements in personalized vascular care and next-generation aneurysm treatment technologies.

LIST OF TOP AORTIC ANEURYSM COMPANIES

• Medtronic
• Endologix
• Gore Medical
• MicroPort Scientific
• Cook Medical
• Terumo Medical
• MAQUET Holding
• Lombard Medical
• JOTEC
• Cardinal Health

List Of Top 2 Companies Market Share

• Medtronic – Holds approximately 31% of the global Aortic Aneurysm Market due to its comprehensive portfolio of endovascular stent graft systems, broad international distribution network across more than 150 countries, and extensive physician training programs supporting high procedural adoption.
• Gore Medical – Accounts for approximately 24% of the global market, supported by strong clinical evidence, durable stent graft technologies, widespread use in abdominal and thoracic aneurysm repair, and consistent adoption across major cardiovascular treatment centers worldwide.

INVESTMENT ANALYSIS AND OPPORTUNITIES

The Aortic Aneurysm Market continues attracting investment because cardiovascular disease remains one of the leading causes of mortality worldwide, while aging populations increase demand for vascular intervention. More than 1.3 million vascular imaging examinations related to aneurysm assessment are performed annually across major healthcare markets, creating sustained demand for diagnostic technologies and endovascular devices. Medical device manufacturers continue expanding production facilities to support increasing global procedure volumes, while physician education programs have increased participation by approximately 20% over the past few years.

Investments are increasingly directed toward artificial intelligence-assisted imaging, three-dimensional procedural planning, and customized stent graft development. Hybrid operating rooms have now been installed in over 60% of tertiary cardiovascular hospitals across developed regions, creating opportunities for advanced surgical equipment suppliers. Emerging economies continue investing in cardiovascular infrastructure, expanding access to minimally invasive vascular treatment. Public health screening initiatives targeting adults above 65 years create additional opportunities for diagnostic imaging providers, vascular implant manufacturers, and healthcare service organizations.

NEW PRODUCT DEVELOPMENT

Product innovation remains a central growth factor within the Aortic Aneurysm Market as manufacturers introduce advanced stent graft platforms, lower-profile delivery systems, and improved imaging technologies. Newly developed delivery catheters now measure less than 16 French in several advanced systems, allowing treatment through smaller vascular access sites and reducing procedural complications. Branched and fenestrated stent graft technologies have expanded treatment eligibility by approximately 24% for patients with complex aneurysm anatomy. More than 30% of newly launched vascular devices incorporate enhanced fixation mechanisms designed to minimize graft migration and improve long-term stability.

Artificial intelligence-assisted planning software enables automated anatomical measurements, reducing planning time while improving device selection accuracy. Three-dimensional visualization systems are increasingly integrated into hybrid operating rooms, improving procedural precision during thoracic and abdominal aneurysm repair. Manufacturers also continue developing biocompatible graft materials with improved flexibility and fatigue resistance to enhance long-term durability. Digital postoperative monitoring platforms now support remote patient surveillance, improving follow-up compliance and enabling earlier identification of potential device-related complications.

FIVE RECENT DEVELOPMENTS (2023-2025)

• January 2023: Medtronic introduced expanded clinical data supporting its advanced endovascular stent graft platform for abdominal aortic aneurysm repair. The updated evidence included treatment outcomes from more than 1,000 patients, demonstrating strong procedural durability and supporting broader physician adoption across specialized vascular centers.
• June 2023: Cook Medical expanded physician education initiatives focused on complex aortic aneurysm repair through advanced simulation-based training programs. The initiative included hands-on procedural education, three-dimensional anatomical planning, and specialized workshops designed to improve physician proficiency with fenestrated and branched endovascular technologies.
• March 2024: Terumo Medical strengthened its vascular intervention portfolio by expanding availability of advanced catheter-based technologies supporting endovascular aneurysm repair. The expansion improved physician access to minimally invasive vascular devices and enhanced procedural efficiency across cardiovascular treatment facilities.
• September 2024: Gore Medical announced additional long-term clinical evidence supporting the performance of its thoracic endovascular stent graft technology. Updated patient follow-up data demonstrated durable device performance, reinforcing physician confidence for complex thoracic aortic aneurysm treatment across global vascular centers.
• February 2025: MicroPort Scientific expanded research activities focused on next-generation endovascular technologies for complex aortic disease management. The initiative emphasized advanced stent graft design, improved delivery system flexibility, and enhanced physician collaboration to support broader treatment options for anatomically challenging aneurysm patients.

AORTIC ANEURYSM MARKET REPORT COVERAGE

The Aortic Aneurysm Market report provides a comprehensive assessment of industry performance across product types, clinical applications, geographic regions, technological developments, and competitive positioning. The report evaluates 2 primary product categories, 3 major application segments, and 4 regional markets using current clinical and industry information. It examines disease prevalence, procedural adoption, diagnostic imaging utilization, and technological advancements influencing treatment decisions. The analysis includes market share estimates, procedural trends, physician adoption patterns, healthcare infrastructure development, and regulatory influences affecting advanced vascular devices.

More than 10 leading manufacturers are evaluated according to product portfolios, innovation strategies, geographic presence, and competitive positioning. The report further assesses advancements in endovascular aneurysm repair, branched and fenestrated stent graft technologies, artificial intelligence-assisted imaging, hybrid operating rooms, and customized vascular implants. Investment trends, strategic opportunities, product development activities, and recent manufacturer initiatives completed between 2023 and 2025 are also covered. The report provides actionable insights for medical device manufacturers, healthcare providers, investors, distributors, research organizations, and policymakers seeking data-driven understanding of the evolving global Aortic Aneurysm Market.